November 30, 2025
Major Breakthrough in Cancer Immunotherapy: One Drug to Kill Multiple Cancers
When it comes to Cancer Immunotherapy, you may have heard of CAR-T and bispecific antibodies, but these therapies have a fatal flaw—they require finding protein targets unique to cancer cells. However, most cancers don't have exclusive proteins, or the targets are also present on normal cells, easily leading to collateral damage and serious side effects. On […]
Read More >
